, Aug. 2, 2013 /PRNewswire/ -- Perrigo Company (NYSE: PRGO, "Perrigo") today announced that it it will release financial results for its fourth quarter and fiscal year 2013 and will provide 'standalone' Perrigo guidance for fiscal year 2014 on
Thursday, August 15, 2013
, at approximately
8:00 a.m. (ET)
. The Company will conduct a conference call at
10:00 a.m. (ET)
Joseph C. Papa
, Perrigo's Chairman, President and Chief Executive Officer.
July 29, 2013
, Perrigo and Elan Corporation, plc announced that they had entered into a definitive agreement (the "Transaction Agreement") under which Elan will be acquired by a new holding company incorporated in
("New Perrigo"). The transaction is expected to close by the end of calendar year 2013. Until the transaction closes, Irish Takeover Rules impose significant requirements on Perrigo in relation to the issuance of new information or guidance outside the scope of that which has already been disclosed in the announcement made pursuant to Rule 2.5 of the Irish Takeover Rules. Perrigo therefore plans to conduct its 2013 Analyst Day after the transaction closes, which will allow the Company to communicate the full benefits of New Perrigo and the value creation for shareholders over the short and long term.
The conference call will be available live via webcast to interested parties in the investor relations section of the Perrigo website at
or by phone at 877-248-9413, International 973-582-2737, and reference ID# 13122087. A taped replay of the call will be available beginning at approximately
1:00 p.m. (ET) Thursday, August 15, 2013
Friday, August 30, 2013
. To listen to the replay, dial 855-859-2056, International 404-537-3406, and use access code 13122087.
From its beginnings as a packager of generic home remedies in 1887,
-based Perrigo Company has grown to become a leading global provider of quality, affordable healthcare products. Perrigo develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements and active pharmaceutical ingredients (API). The company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The company's primary markets and locations of logistics operations have evolved over the years to include
the United States
. Visit Perrigo on the Internet at
No Offer or Solicitation
THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER TO SELL, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE OR EXCHANGE, ANY SECURITIES OR THE SOLICITATION OF ANY VOTE OR APPROVAL IN ANY JURISDICTION, NOR SHALL THERE BE ANY SALE, ISSUANCE, EXCHANGE OR TRANSFER OF THE SECURITIES REFERRED TO IN THIS ANNOUNCEMENT IN ANY JURISDICTION IN CONTRAVENTION OF APPLICABLE LAW.